Research and Development

The UK pharma trade body the ABPI has appointed Richard Corbett as its new executive director of commercial. Corbett will …

A Parliamentary body has been created to highlight the contribution the life sciences sector makes to the economy, and boost …

A judge is set to rule on a controversial legal challenge to the requirement for the pharma industry to register …

The judicial review brought by Richmond Pharmacology against the Health Research Authority – erroneous, a waste of public money and …

A judge will today hear arguments from the Health Research Authority and campaigners who are contesting a judicial review of …

UK pharma giant GSK is partnering with the Medical Research Council, to study the biological mechanisms behind common inflammatory diseases. …

UK-based drug development company Ergomed has appointed Andrew Mackie as chief business officer, and to its board as executive director.Mackie …

The UK’s largest pharma company and the UK’s newest biomedical research facility are partnering up to begin an innovation collaboration.The …

The Government has signed-off on the transfer of Public Health England’s drug development and production arm into a state-owned biopharma …

The Government is urging pharma companies to participate in the Accelerated Access Review, and will launch a website for firms …

Chancellor George Osborne is giving UK drug R&D a £5 million vote of confidence, after promising new investment into two …

A cancer drug in development by Roche has performed well in a mid-phase clinical trial – prompting the Swiss firm …

Novo Nordisk is taking the first steps towards adding another type 2 diabetes drug to its portfolio, after announcing positive …

DBV Technologies has appointed Dr Hugh Sampson as its chief scientific officer. The French biotech company is developing the Viaskin peanut allergy treatment patch. Dr …

Praluent, the new heart drug from Sanofi and Regeneron, has met its primary endpoint in a Phase III study in …